*Copyright permission pending - if interested in this measure, please contact us to discuss possible additional charges associated with this particular instrument
Additionally, as the technology partner of the International Consortium for Health Outcomes Measurement (ICHOM), OutcomeMD works to respect ICHOM’s recommended PROMs for chronic kidney disease when possible.
For nephrology conditions that encompass more than one patient area or domain (for example, kidney disease quality of life + pain + fatigue), OutcomeMD has developed clusters of multiple PROs based on validated medical literature. With our PRO clusters, you will always have a comprehensive view of how your patient is progressing.
The value of OutcomeMD to Nephrology:
Provide comprehensive care management by monitoring a suite of symptoms that are relevant to your patients’ wellness
- End-stage renal disease (ESRD) leads to worse physical functioning for patients than many other chronic conditions,1 and recent work by the Standardized Outcomes in Nephrology group has demonstrated that ESRD patients prioritize outcomes like fatigue, ability to travel, impact on family and work over more conventional outcomes such as hospitalization and mortality2
- Quickly identify your patients who are experiencing detrimental symptoms and who may need additional clinical attention or a change in treatment
- For patients with chronic kidney diseases, the presence of symptoms is associated with both decreased quality of life and increased mortality, and the use of patient reported outcome measures (PROMs) to measure symptoms that could flag declined health can expedite critical treatment modifications3
Did your patient have a great outcome? With OutcomeMD, your patients with good outcomes can now publicly celebrate their improvement with ease by posting on their social media accounts (lead generation) and on your review sites (reputation management)!
1Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV cost and services utilization study. Am J Med 2000;108:714–22.
2Urquhart-Secord R, Craig JC, Hemmelgarn B, et al. Patient and caregiver priorities for outcomes in hemodialysis: An international nominal group technique study. Am J Kidney Dis 2016;68:444–54.
3Murtagh FE, Sheerin NS, Addington-Hall J, Higginson IJ. Trajectories of illness in stage 5 chronic kidney disease: A longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol 2011;6:1580–90.